Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Harada

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|June 21, 2017
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancerSatoshi Igawa, Sakiko Otani, Shinichiro Ryuge, et al.
Oncology|April 27, 2018
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR MutationsNoriko Nishinarita, Satoshi Igawa, Masashi Kasajima, et al.
Internal Medicine (Tokyo, Japan)|June 8, 2018
Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung AdenocarcinomaYoshiro Nakahara, Tomoya Fukui, Masayuki Shirasawa, et al.
Plos One|April 20, 2019
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancerMasayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, et al.
Cancer Management and Research|December 28, 2018
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung diseaseSatoshi Igawa, Noriko Nishinarita, Akira Takakura, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|June 21, 2017
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancerSatoshi Igawa, Sakiko Otani, Shinichiro Ryuge, et al.
Oncology|April 27, 2018
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR MutationsNoriko Nishinarita, Satoshi Igawa, Masashi Kasajima, et al.
Internal Medicine (Tokyo, Japan)|June 8, 2018
Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung AdenocarcinomaYoshiro Nakahara, Tomoya Fukui, Masayuki Shirasawa, et al.
Plos One|April 20, 2019
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancerMasayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, et al.
Cancer Management and Research|December 28, 2018
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung diseaseSatoshi Igawa, Noriko Nishinarita, Akira Takakura, et al.
Pageof 3